Karen Ege Olsen

2.5k total citations
62 papers, 1.8k citations indexed

About

Karen Ege Olsen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Karen Ege Olsen has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Karen Ege Olsen's work include Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and HER2/EGFR in Cancer Research (5 papers). Karen Ege Olsen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Treatments and Mutations (7 papers) and HER2/EGFR in Cancer Research (5 papers). Karen Ege Olsen collaborates with scholars based in Denmark, United States and Sweden. Karen Ege Olsen's co-authors include Per Westermark, Knut Sletten, Jens Overgaard, Birgitte Rasmussen, Bent Ejlertsen, Helle Knudsen, Andreas Schönau, Kirsten Vang Nielsen, Eva Balslev and Ann Knoop and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Karen Ege Olsen

62 papers receiving 1.7k citations

Peers

Countries citing papers authored by Karen Ege Olsen

Since Specialization

Citations

This map shows the geographic impact of Karen Ege Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Ege Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Ege Olsen more than expected).

Fields of papers citing papers by Karen Ege Olsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Ege Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Ege Olsen. The network helps show where Karen Ege Olsen may publish in the future.

Co-authorship network of co-authors of Karen Ege Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Ege Olsen. A scholar is included among the top collaborators of Karen Ege Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Ege Olsen. Karen Ege Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Forecasting lung cancer incidence, mortality, and prevalence to year 2030 2021 ·BMC Cancer ·Erik Jakobsen, Karen Ege Olsen, Mette Bliddal, Malene Hornbak, Gitte Fredberg Persson, Anders Green	34
2	Short communication: Iodine concentrations in serum, milk, and tears after feeding Ascophyllum nodosum to dairy cows—A pilot study 2016 ·Journal of Dairy Science ·U.S. Sorge, (unknown), Ayhan Baştan, (unknown), Karen Ege Olsen, B.A. Crooker	9
3	Serotypes and Antimicrobial Resistance in Salmonella enterica Recovered from Clinical Samples from Cattle and Swine in Minnesota, 2006 to 2015 2016 ·PLoS ONE ·Samuel L. Hong, Albert Rovira, Peter R. Davies, Christina A. Ahlstrom, Petra Muellner, Aaron Rendahl, Karen Ege Olsen, Jeff B. Bender, Scott J. Wells, Andrés Pérez, Julio Álvarez	54
4	Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer 2015 ·Clinical Cancer Research ·Tom Dønnem, Sigurd M. Hald, Erna‐Elise Paulsen, Elin Richardsen, Samer Al‐Saad, Thomas K. Kilvær, Odd Terje Brustugun, Åslaug Helland, Marius Lund‐Iversen, Mette Poehl, Karen Ege Olsen, Henrik J. Ditzel, Olfred Hansen, Khalid Al‐Shibli, Yury Kiselev, Torkjel M. Sandanger, Sigve Andersen, Francesco Pezzella, Roy M. Bremnes, Lill‐Tove Busund	252
5	Sarkoidose kan debutere med neurologiske symptomer 2014 ·Ugeskrift for Læger ·(unknown), Inger Marie Jensen Hansen, (unknown), Karen Ege Olsen	1
6	Tissue Microarrays in Non–Small-Cell Lung Cancer: Reliability of Immunohistochemically-Determined Biomarkers 2013 ·Clinical Lung Cancer ·Mette Pøhl, Karen Ege Olsen, René Holst, Henrik J. Ditzel, Olfred Hansen	13
7	Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus 2012 ·Journal of Clinical Virology ·Ruth Chin, (unknown), Claire L. Gordon, Karen Ege Olsen, Ian Barr, Lorena E. Brown, David C. Jackson, Joseph Torresi	6
8	Availability, Brands, Labelling and Salmonella Contamination of Raw Pet Food in the Minneapolis/St. Paul Area 2012 ·Zoonoses and Public Health ·(unknown), (unknown), Karen Ege Olsen, Jeff B. Bender	22
9	Impact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic 2011 ·Scandinavian Journal of Infectious Diseases ·Benjamin W. Teh, Karen Ege Olsen, Jim Black, Allen Cheng, Craig Aboltins, (unknown), Paul D. R. Johnson, M. Lindsay Grayson, Joseph Torresi	32
10	Minimally invasive diagnosis of sarcoidosis by EBUS when conventional diagnostics fail. 2010 ·PubMed ·Jens Eckardt, Karen Ege Olsen, Ole Dan Jørgensen, Peter B. Licht	17
11	Metastasis in the subcarinal lymph node with unknown primary tumor 2010 ·Thoracic Cancer ·Jens Eckardt, Karen Ege Olsen, Henrik Petersen	2
12	Methicillin-resistantStaphylococcus aureusin Resident Animals of a Long-term Care Facility 2009 ·Zoonoses and Public Health ·Karen Coughlan, Karen Ege Olsen, Dave Boxrud, Jeff B. Bender	19
13	Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group 2005 ·Journal of Clinical Oncology ·Ann Knoop, Helle Knudsen, Eva Balslev, Birgitte Rasmussen, Jens Overgaard, Kirsten Vang Nielsen, Andreas Schönau, K. Gunnarsdóttir, Karen Ege Olsen, Henning T. Mouridsen, Bent Ejlertsen	244
14	Quantitative PCR – new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neuDNA quantification with LightCycler real‐time PCR in comparison with immunohistochemistry and fluorescencein situhybridization 2004 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), Boe Sandahl Sørensen, Jens Overgaard, Karen Ege Olsen, Lise Mette Rahbek Gjerdrum, Ebba Nexø	27
15	Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes 2004 ·Acta Oncologica ·Karen Ege Olsen, Helle Knudsen, Birgitte Rasmussen, Eva Balslev, Ann Knoop, Bent Ejlertsen, Kirsten Vang Nielsen, Andreas Schönau, Jens Overgaard, (unknown)	61
16	The Distribution of Mycobacterium avium ssp. paratuberculosis in the Environment Surrounding Minnesota Dairy Farms 2004 ·Journal of Dairy Science ·Eran A. Raizman, Susan Wells, S. Godden, R. Bey, (unknown), (unknown), Karen Ege Olsen	93
17	Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers 1999 ·European Radiology ·Bedrich Viták, Karen Ege Olsen, (unknown), L-G Arnesson, Olle Stål	30
18	Fragments of the Constant Region of Immunoglobulin Light Chains Are Constituents of AL-Amyloid Proteins 1998 ·Biochemical and Biophysical Research Communications ·Karen Ege Olsen, Knut Sletten, Per Westermark	47
19	Frequent allelic losses on chromosome 13q in human male breast carcinomas 1997 ·European Journal of Cancer ·Sten Wingren, (unknown), Marco Gentile, Karen Ege Olsen, Thomas Hatschek, Peter Söderkvist	8
20	Langerhans cells and subsets of lymphocytes in the nasal mucosa 1991 ·Apmis ·Henrik Hellquist, Karen Ege Olsen, Kristina Irander, Elin Karlsson, Lars Ödkvist	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact